ABT vs CASY · P/E 25, rev $44.33B vs P/E 36, rev $17.56B
Abbott Laboratories (ABT) versus Caseys General Stores Inc (CASY) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Caseys General Stores Inc (CASY) is a specialty retail company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported CASY revenue for 2026-04-30 was $17.56B. Net income was $714.4M. Revenue was up 10.2% from 2025-04-30 to 2026-04-30. CASY currently screens at market cap $19.56B and trailing P/E 36.0.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. CASY currently screens at market cap $19.56B and trailing P/E 36.0.
Not investment advice. Open the ABT and CASY stock pages for the full models.
Not investment advice.